LLY Eli Lilly and Company
Healthcare
Price
$1,223.73
Intrinsic value
$400.80
Buy price
$320.64
Discount
-205.3%
DCF walkthrough
Near-term growth (g1)25.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $28,083,000,000.00
- Total debt
- $54,907,998,208.00
- Cash & STI
- $8,949,999,616.00
- Shares out.
- 893,671,000
Overvalued
Intrinsic value$400.80
Buy price (with MOS)$320.64
Current price$1,223.73
Discount to intrinsic value-205.3%
7-step quality scorecard
ROE quality
HIGH_DISTORTED- Average ROE
- 64.8%
- Current ROE
- 77.8%
- Minimum ROE
- 48.6%
Debt quality
LEVERAGED- Debt / Equity
- 2.07x
Moat proxy
MODERATE_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.05x
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- revenueCAGR
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 13.6%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.